Patent details

EP3525813 Title: BROADLY NEUTRALIZING ANTIBODY TARGETING THE EBOLAVIRUS GLYCOPROTEIN INTERNAL FUSION LOOP

Basic Information

Publication number:
EP3525813
PCT Application Number:
US2017055795
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP178594339
PCT Publication Number:
WO2018071345
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BROADLY NEUTRALIZING ANTIBODY TARGETING THE EBOLAVIRUS GLYCOPROTEIN INTERNAL FUSION LOOP
French Title of Invention:
ANTICORPS NEUTRALISANT À LARGE SPECTRE CIBLANT LA BOUCLE DE FUSION INTERNE DE LA GLYCOPROTÉINE DU VIRUS EBOLA
German Title of Invention:
BREIT NEUTRALISIERENDE ANTIKÖRPER GEGEN DIE INTERNE GLYCOPROTEINFUSIONSSCHLEIFE DES EBOLAVIRUS
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
16/05/2024
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
27/05/2024
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
17/04/2024
Unitary Effect Registration Date:
27/05/2024
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
09/10/2017
Grant date:
17/04/2024
EP Publication Date:
21/08/2019
PCT Publication Date:
19/04/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/04/2024
EP B1 Publication Date:
17/04/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
09/10/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/04/2024
 
 

Name:
Razi Holdings, Inc.
Address:
4 Research Court, Suite 300, Rockville, MD 20850, United States (US)

Name:
The University of Maryland
Address:
UM Ventures 7809 Regents Dr., 0134 Lee Bldg., College Park, MD 20742, United States (US)

History of Owners

From:
10/04/2024
To:
19/04/2024

Name:
Razi Holdings, Inc.
Address:
4 Research Court, Suite 300, Rockville, MD 20850, United States (US)

Name:
The University of Maryland
Address:
2130 Mitchell Building 7999 Regents Drive, College Park, Maryland 20742, United States (US)

Inventor

1

Name:
HOWELL, Katie A.
Address:
United States (US)

2

Name:
ZHAO, Xuelian
Address:
United States (US)

3

Name:
HOLTSBERG, Frederick Wayne
Address:
United States (US)

4

Name:
LI, Yuxing
Address:
United States (US)

5

Name:
AMAN, Mohammad Javad
Address:
United States (US)

Priority

Priority Number:
201662406598 P
Priority Date:
11/10/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/00; A61K 39/42; A61K 39/395; C07K 16/10;

Publication

European Patent Bulletin

1

Issue number:
202416
Publication date:
17/04/2024
Description:
Grant (B1)

2

Issue number:
202421
Publication date:
22/05/2024
Description:
Change of owner's name or address

3

Issue number:
202425
Publication date:
19/06/2024
Description:
Unitary Effect Request Receipt

4

Issue number:
202426
Publication date:
26/06/2024
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages